Polycomb complexes (PRC1 and PRC2) 
Introduction
The Polycomb group of complexes (PcG) are implicated in development, cancer, and stem cell fate decisions (Di Croce and Helin, 2013) . They are classified as two main complexes, the Polycomb repressive complexes 1 (PRC1) and 2 (PRC2) (Morey and Helin, 2010) . PRC2 comprises three core subunits:
Eed, Suz12, and the histone methyltransferases Ezh1/2, which deposit di-and tri-methylation on lysine 27 of the histone H3 (H3K27me2/3) (Cao et al., 2002) .
PRC1 contains the E3 ligases Ring1A/B, which monoubiquitinates lysine 119 at histone H2A (H2AK119ub) (Wang et al., 2004) . PRC1 complexes can be further distinguished based on their subunit composition as canonical PRC1, which contains Cbx proteins, or noncanonical PRC1, which lacks Cbx proteins. The high level of heterogeneity in the architecture of different PRC1 complexes suggests that their specific gene targets, recruitment mechanisms, and enzymatic activities are context specific. Consistently, we and others have shown that cPRC1 complexes interchange Cbx7 in pluripotent embryonic stem cells (ESCs) for Cbx2 and Cbx4 in differentiating ESCs O'Loghlen et al., 2012) .
Although Polycomb activity is mainly associated with gene repression, Polycomb complexes can also bind to active promoters, where they regulate gene expression positively (Creppe et al., 2014; Frangini et al., 2013; Schaaf et al., 2013; Suzuki et al., 2002) . Further, in MEF cells, depleting the non-coding RNA (ncRNA) lincRNA-p21 upregulated of a subset of PRC2 targets, although H3K27me3 remained unaffected in these promoters (and the presence of Cbx was not investigated) (Dimitrova et al., 2014) . It thus seems plausible that certain genes containing Cbx proteins and H3K27me3 are expressed in specific cellular processes.
PRC1 heterogeneity is further defined by the six Polycomb-group RING finger protein (Pcgf) paralogs. Pcgf2/Mel18 (referred to herein as Mel18) and Pcgf4/Bmi1 enhance Ring1B-mediated enzymatic activity in vitro, through a direct interaction of their RING domains (Buchwald et al., 2006; Elderkin et al., 2007; Li et al., 2006) . Pcgf4/Bmi1 expression is strongly upregulated during neuronal differentiation and is essential for neural stem cells (NPC) maintenance and hematopoietic stem cell (HSC) self-renewal (Bruggeman et al., 2005; Oguro et al., 2010; Smith et al., 2011; Zencak et al., 2005) . Pcgf1/NSPc1, together with the transcription factor Runx1, also regulate HSC differentiation and self-renewal (Ross et al., 2012) . Although it is well established that Polycomb complexes are essential regulators of ESC differentiation in vitro (Laugesen and Helin, 2014) , very little is known about the functions of Pcgf proteins in this context. Mel18, Pcgf1, and Pcgf6 are highly expressed core subunits of different PRC1 complexes in ESCs, suggesting that they, similar to the Cbx proteins, can functionally define PRC1 activities. Indeed, Pcgf6 was recently demonstrated to be functionally essential for ESC self-renewal (Zdzieblo et al., 2014) . PRC1 activities and functions have been extensively studied mainly in the context of Ring1A/B depletion, but PRC1 heterogeneity-in both complex composition and activitynow suggests that specific PRC1 complexes have unique functions during development and stem cell differentiation.
To date, no PRC1 members have been described to be important for in vivo or in vitro cardiac development and differentiation, yet the PRC2 core subunit Ezh2 has been described to be essential for cardiomyocyte proliferation, survival, and postnatal cardiac homeostasis (Delgado-Olguin et al., 2012) , and Eed and Jarid2 are required for heart formation (Laugesen and Helin, 2014 ).
Mel18 is not essential during embryogenesis, but mutant mice have growth deficiencies, homeotic transformations, and hematopoietic defects and die a few days or weeks after birth (Akasaka et al., 2001) . Skeletal and hematopoietic tissues derive from the mesoderm lineages, suggesting that Mel18 could specialize during development.
Here, we have characterized the function of Mel18 in ESC pluripotency and differentiation. We show that Mel18 binds to cPRC1 target genes in ESCs, and that it is essential for stabilizing cPRC1 and for cPRC1-mediated gene repression.
Using direct differentiation assays of ESCs to cardiomyocytes, cartilage, and neuroprecursor (NPS) cells, we elucidate a specific function of Mel18 during the early stages of mesoderm differentiation. Mechanistically, we found that, during cardiac differentiation, the Mel18-PRC1 complex not only represses pluripotency genes, BMP-negative regulators, and cell fate identity genes, but also facilitates transcription of transcription factors that are essential for differentiation of early cardiac mesoderm precursors.
Results

Mel18 Binds to cPRC1 Target Genes, Regulates Transcription, and
Stabilizes the cPRC1 Complex only in ESCs
Mel18 is extensively considered to be an integral subunit of cPRC1 in ESCs (Luis et al., 2012 ), yet no genome-wide studies of Mel18 binding to chromatin have been reported to date. We thus performed Mel18 chromatin immunoprecipitation experiments with massive-parallel sequencing (ChIP-seq).
We identified 6,593 peaks, resulting in 4,162 target genes ( Figure 1A ; Table S1 ).
Heat maps of Mel18 ChIP-seq signals revealed that all Mel18 targets are also cooccupied by Ring1B and Cbx7 and are decorated with H2AK119ub ( Figure 1A ).
Further analyses of Mel18, Ring1B, Cbx7, and H2AK119ub ChIP-seq signals at the 4,162 Mel18 target genes corroborated that Mel18 targets are PRC1 target genes (Figures 1B and 1C) . These results further highlight that Mel18 occupancy is always within the context of the PRC1 complex.
To determine whether Mel18 is necessary for both ESC self-renewal and cPRC1 stability, we depleted Mel18 using two specific shRNAs ( Figure S1A ).
Analysis of the pluripotency markers and alkaline phosphatase (AP) staining of control and Mel18 knock-down cells suggested that Mel18 is not required for ESC self-renewal (Figure S1B-S1E). Western blots of control and Mel18 knockdown (KD) extracts suggested that Mel18 is required for stability of Phc1 and Cbx7 proteins ( Figure 1D ). Pcgf proteins directly interact with Phc proteins through their RAWUL domains (Junco et al., 2013) and with Ring1B through their RING domains (Li et al., 2006) . However, as Pcgf proteins do not directly interact with Cbx proteins, the reduced levels of Cbx7 in Mel18-depleted cells suggested that Mel18 is required for cPRC1 complex stability ( Figure 1D ).
Moreover, endogenous co-immunoprecipitation (co-IP) experiments using a Ring1B antibody indicated that cPRC1 was strongly destabilized, as Phc1 and Cbx7 interactions were significantly reduced when Mel18 was depleted ( Figure   1D ). As expected, the Rybp-Ring1B interaction was not affected. We conclude that Mel18 depletion specifically disrupted the cPRC1 complex in ESCs, while the ncPRC1 complex remained unaffected.
We then asked whether Ring1B, Cbx7, and PRC2 binding to chromatin was affected in Mel18 KD cells. ChIP-qPCR experiments indicated that Cbx7 and Ring1B recruitment was strongly reduced in shMel18 cells ( Figure 1E ), concomitant with a slight reduction of H2AK119ub levels (Figure S1F, left panel) and in Suz12 occupancy ( Figure S1F , right panel). As Cbx7 is required for efficient binding to chromatin of Ring1B, Mel18, and PRC2 , we cannot exclude that the reduced occupancy of Ring1B in Mel18 KD cells stemmed from reduced Cbx7 protein levels. Although we observed a 25% reduction of H2AK119ub levels and Suz12 binding in Mel18-depleted ESCs ( Figure S1F , left panel), global H2AK119ub and H3K27me3 levels remained unaffected ( Figure S1G ).
We observed that reduced occupancy of cPRC1 resulted in gene derepression ( Figure S1H ). RNA-seq experiments (Table S1 ) revealed that in shMel18 ESCs, 868 genes were deregulated (with 720 upregulated and 148 downregulated) ( Figure 1F , left panel). As anticipated, Ring1B mutant cells have a major impact on gene deregulation ( Figure 1F , right panel). Importantly, almost 50% of the up-regulated genes in Mel18 KD cells are Mel18 target genes, and from those, 95% are co-bound by Ring1B ( Figure 1G ). This result is consistent with our Mel18 ChIP-seq analysis, in which all Mel18 target genes were also Ring1B targets, and also denotes that Mel18 is important for maintaining gene repression. Gene ontology (GO) analysis of upregulated Mel18 target genes scored as genes strongly associated to mesoderm genes, and to a lesser extent, as ectoderm genes, suggesting a particular role for Mel18 in mesoderm cell fate ( Figure 1H ).
Mel18 is Necessary for Proper Cardiac Differentiation of Embryoid Bodies
We next asked whether Mel18 is essential for ESC differentiation. We first generated embryoid bodies (EBs) from control and Mel18 KD ESCs. EBs mimic early development of the embryo and are often used as a differentiation assay to test ESC pluripotency (Evans and Kaufman, 1981) . AP staining of EBs at day 7 showed that more than double the amount of colonies appeared to be APpositive in the shMel18 ESCs as compared to the control ESCs ( Figure S2A ), suggesting that a lack of Mel18 impairs proper differentiation. We then generated 12-days-old EBs, which have cells from all three germ layers. From days 2-10, shMel18 EBs were macroscopically very similar to control EBs; however, at day 12, they exhibited an irregular internal bulk and did not present any sign of beating, which is usually observed from day 10 in normal EBs ( Figure   2A and data not shown). Although pluripotency genes were efficiently downregulated in both control and shMel18 12-day-old EBs, we found striking differences in the expression of mesoderm/cardiac markers ( Figure 2B ).
To have a better readout of the cardiac differentiation potential of the shMel18 ESCs, we modified the EB differentiation protocol to allow quantification of beating EBs ( Figure 2C ). At day 11, all control EBs were beating, while only 20-30% of shMel18 EBs contained beating clusters ( Figure 2C ).
Analysis of cardiac-specific genes confirmed that shMel18 EBs do not properly differentiate into beating cardiomyocytes ( Figure 2D ).
As Phc1 protein stability is greatly impaired in shMel18 ESCs, we next tested whether the observed differentiation defects were due to Phc1 depletion. Co-IPs experiments using a Ring1B antibody indicated that Ring1B and Mel18 strongly interacted, regardless of Phc1, but that Mel18 levels were slightly decreased, and that the Cbx7 interaction was strongly reduced in Phc1 KD cells ( Figure S2B ).
shPhc1 ESCs also de-repressed Polycomb target genes ( Figure S2C ), and importantly, depletion of Phc1 did not affect the cardiac differentiation of ESCs ( Figure S2D ). Thus, we conclude that the cardiomyocyte differentiation defect observed in Mel18 KD cells was not Phc1 dependent.
Mel18 is Essential for ESCs to Differentiate into Early Cardiac-Mesoderm Precursors
As EB formation stimulates a chaotic ESC differentiation, it was difficult to estimate whether the observed differentiation defects were specific for the mesoderm lineage or rather were due to secondary differentiation defects. To overcome this, we used a protocol for differentiating ESCs into a highly homogenous population of beating cardiomyocytes (Kattman et al., 2011) .
Further, as early steps of cardiac differentiation, such as formation of early cardiac-mesoderm precursors cells (MES) and cardiac precursor (CP) cells, can be studied in this protocol, we asked whether Mel18 is required for direct cardiomyocyte differentiation and, if so, at which stage of cardiac differentiation Mel18 function is required ( Figure 3A ).
Mel18-depleted ESCs formed EB-containing MES cells (as determined by the co-expression of the surface markers Flk1 [Kdr] and the Pdgfα receptor [Kattman et al., 2011] ); however, these were not as round and smooth as those formed from control MES EBs ( Figure 3B ). In our experiments, 0.1 ng/ml and 0.2 ng/ml of BMP4 generated around 60% and 70-80% of Flk1 + and Pdgfα + cells, respectively ( Figure 3C) (Table S1 ). To control for the differentiation method, we first analyzed genes that were up-or downregulated by at least five-fold from control ESCs and MES cells (with FPKM ≥1 in ESCs and MES cells). We found 489 genes upregulated and 1,311 genes downregulated in MES cells ( Figure 3D ). As expected, upregulated genes were mainly associated with mesoderm differentiation, and genes related to pathways essential for MES differentiation (e.g. BMP, FGF/Brachyury, and Wnt). In contrast, downregulated genes were mainly classified as embryonic stem cell genes ( Figure S3A ).
We then analyzed the gene expression changes, using a 2-fold cut-off, in Mel18-depleted MES cells as compared to control MES cells. We found 421 genes to be aberrantly upregulated in Mel18-depleted MES cells. These genes are involved in ectoderm differentiation and embryonic stem cell pluripotency, suggesting that Mel18 KD MES cells have lost their cell identity and are not able to fully differentiate ( Figure S3B ). In contrast, the 445 downregulated genes were involved in mesoderm cardiomyocyte differentiation, with a strong impairment of the gene networks associated to early mesoderm differentiation ( Figure S3C ). Similar gene categories were also observed when changes in gene expression upon Mel18 depletion were analyzed using a 5-fold cut-off (data not shown).
Comparing the expression of the upregulated genes in ESCs from control MES cells with the deregulated genes in shMel18 MES cells revealed that almost 50% of the upregulated genes in control MES cells (199 out of 489 genes) were downregulated by at least 2-fold in shMel18 MES cells ( Figure 3D ). These genes are mainly classified as mesoderm genes and, more specifically, are involved in cardiovascular system development ( Figure 3E ). Almost 10% (150 of 1,311) of the genes downregulated during MES differentiation were aberrantly upregulated in Mel18-depleted MES cells; interestingly, these genes were mainly involved in ESC pluripotency ( Figure 3E ). RT-qPCR analysis confirmed the reduced expression of MES-specific genes in Mel18-depleted MES cells ( Figure   3F ). T/Brachyury expression was not affected in shMel18 MES cells, while Mesp1 expression (which is downstream of T/Brachyury during mesoderm development [David et al., 2011; Herrmann et al., 1990; Saga et al., 1999] ) was strongly downregulated. Thus, Mel18 is not essential for the initial mesoderm cell determination but is an essential regulator of the MES-specific gene signature, as its depletion resulted in a block of differentiation of early cardiac mesoderm precursors.
PRC1 Complex Composition and Genome-Wide Binding in MES Cells
We next analyzed the composition and the genome-wide distribution of PRC1 in MES cells. We first determined that Mel18 interacts with Ring1B in MES cells ( Figure 4A ) and measured the expression levels of all cPRC1 and ncPRC1 subunits ( Figure 4B ). Cbx7 and Phc1 were strongly downregulated in MES cells, with Cbx2 and Phc2 the main Cbx and Phc family members expressed in these cells. Mel18 and Pcgf6 were the strongest Pcgf proteins expressed in MES cells ( Figure 4B ). Strikingly, while global H2AK119ub levels were constant in ESCs as compared to MES cells, H3K27me3 levels were reduced, concomitant with an accumulation of H3K27ac levels ( Figure 4C ). Concordant with the effects of Mel18 depletion in ESCs, the levels of H2AK119ub and H3K27me3 also remained unaltered in shMel18 MES cells ( Figure S4A ). Western blot analysis of several PRC1 subunits confirmed that Cbx2 and Phc2 were strongly upregulated, and that Mel18 was marginally downregulated in MES cells ( Figure 4D ). Upon Mel18 depletion, Cbx2 protein levels were strongly impaired, yet Rybp, Ring1B, and Cbx6 remained unaffected ( Figure 4D ). These data suggested that a new cPRC1 complex containing Cbx2 and Phc2 was assembled in MES cells, and that Mel18 was required to stabilize cPRC1 but not (as in ESCs) ncPRC1.
To study the architecture of the PRC1 complex in ESCs and MES cells, we generated an ESC line that expressed endogenous levels of a Flag-Avi-tagged Ring1B ( Figure 4E ). Mass spectrometry (MS) analysis confirmed that Ring1B was associated with at least three different known complexes in ESCs: the cPRC1, ncPRC1, and E2F6-PRC1 complexes O'Loghlen et al., 2012; Qin et al., 2012; Tavares et al., 2012; Wu et al., 2013) (Figure S4B ). In MES cells, Ring1B strongly associated with Mel18, Pcgf6, Rybp, Cbx2, and Phc2 in MES cells.
Interestingly, we only found Pcgf6 as a core subunit of the E2F6-PRC1 complex, suggesting that this complex might not be involved in ESC differentiation into MES cells ( Figure 4F ). We next analyzed a time course of ESC-to-MES cell differentiation to determine in which time frame the switch of the cPRC1 complex composition occurs. Changes in protein levels of PRC1 subunits seemed to be cytokine dependent, since major protein changes occurred 24 hours postinduction ( Figure S4C ). In agreement with reduced levels of H3K27me3 in MES cells, Ezh2 was strongly downregulated during ESC differentiation ( Figure S4C ).
We did not observed changes in Ezh1 expression at these differentiation stages (Table S1) .
We next performed ChIP-seq experiments of Ring1B, Mel18, Rybp, and Cbx2 in MES cells (Table S1 ). As expected, Mel18, Ring1B, and Rybp occupied genes not previously occupied by PRC1 in ESCs and were displaced from genes previously occupied in ESCs, indicating a partial re-localization of PRC1 genome binding in differentiating cells ( Figure 4G) . Surprisingly, de novo Ring1B target genes in MES cells were mainly associated to metabolic processes ( Figure S4D ).
Cbx7 binding is substituted for Cbx2 in 1,589 genes previously bound by Cbx7 in ESCs , and that Cbx2 binds to 1,382 MES-specific genes ( Figure 4G and Figure S4E -F). Cbx7 ESC genes and common Cbx7/Cbx2 target genes in ESC/MES cells were related to development, yet Cbx2 MES cell targets were also strongly associated with metabolic processes ( Figure S4E ).
Detailed analyses of Ring1B, Mel18, Rybp, and Cbx2 target genes disclosed at least six different types of genes robustly bound by different combinations of PRC1 subunits. A genome browser screenshot of a large region of chromosome 1
shows genes co-bound by all four PRC1 subunits (#1), by Ring1B either alone (#2) or with Rybp (#3), or by Mel18 and Rybp but not Cbx2 (#4) ( Figure 4H ). We also found Rybp bound to 1,058 genes that contained no traces of any PRC1 subunit (Morey et al., 2013) , and genes with Mel18, Ring1B, and Cbx2 without Rybp ( Figure 4I ).
The 2,186 genes co-bound by Ring1B, Mel18, Cbx2, and Rybp ( Figure 4I) were classified as developmental genes and more specifically, as ectoderm and mesoderm genes ( Figure 4J ). We also found examples of genes that were cobound by all four PRC1 members involved in cardiac differentiation (Bruneau, 2013) , endoderm differentiation, and pluripotency/ectoderm ( Figures S4G and   S4H ).
Hypothesizing that genes bound by different combinations of PRC1 subunits might be expressed differently, we intersected our RNA-seq of control MES cells with the different ChIP-seq data sets and with an H3K27me3 data set (Wamstad et al., 2012) . Indeed, Ring1B and Rybp target genes that do not contain Mel18, Cbx2, and/or H3K27me3 were expressed at higher levels than genes containing all PRC1 members and PRC2 ( Figure 4K ). Moreover, genes containing Cbx2 but not Rybp (class 5 versus class 6) were also more repressed than the genes containing Rybp but not Cbx2 (Morey et al., 2013) (Figure 4K ). GO analysis of the six gene classes indicated that different genes containing particular combinations of PRC1 subunits have specific biological functions (Table S1 ).
To substantiate the observation that Polycomb-containing genes are transcriptionally active, we looked for H3K36me3 histone modifications (Wamstad et al., 2012) . Almost all genes from the classes 2, 3, and 4 contained H3K36me3, thus confirming that they are active ( Figure 4L ; Figure S4I ) and suggesting that recruitment of Ring1B or Rybp per se was not enough to repress transcription. We thus hypothesized that they might function as co-activators.
Interestingly, we also observed that about one-third of class 1 genes also contained H3K36me3 ( Figure 4L ; Table S1 ). GO analysis revealed that these genes were mainly associated with cell-cell adhesion and heart development ( Figure 4M ). Genes within this category are strongly related with the BMP pathway and the transcription factors indispensable for early heart development (Table S1) . Genes containing H3K36me3 from the six classes have different biological functions ( Figure S4J ), suggesting that genes containing different combinations of PRC1 members and histone modifications regulate distinct cellular pathways and processes. Overall, these data demonstrate that a new cPRC1 complex was assembled in MES cells and that cPRC1 and ncPRC1 complexes bind to more than 2,000 genes in these cells, yet different gene classes can contain distinct combinations of Polycomb subunits. Strikingly, binding of Polycomb proteins was not always associated with gene repression.
Mel18 Directly Regulates Expression of MES-Specific Genes
We hypothesized that the Mel18-mediated phenotype in MES cells might be connected with the direct regulation of genes encoding transcription factors directing cardiac differentiation. Since the set of 647 class 1 active genes contained Mel18 (see Figure 4L ), we investigated whether Mel18 is also involved in gene transcription.
Compared to their wild-type counterparts, Mel18-depleted MES cells aberrantly deregulated a very similar number of genes, with an altered expression of more than 300 Mel18 targets ( Figure 5A) . A higher number of Mel18 targets were downregulated (201) than upregulated (116) ( Figure 5A ).
The downregulated 201 genes were expressed and contained H3K36me3 in wild-type cells, suggesting again that Mel18 might be required for proper gene transcription of these genes. To confirm that Mel18 was bound to H3K36me3-containing genes, we performed a sequential Mel18/H3K36me3 ChIP assay ( Figure 5B ). GO analysis revealed that the Mel18 targets downregulated upon its depletion were mainly related to mesoderm specification, whereas the upregulated genes were associated to regulation of the other cell linages and stem cells ( Figure 5C ).
To strength the observation that Mel18 might control expression of active genes in MES cells, we selected the highest-induced genes from ESC-to-MES differentiation, which were upregulated by at least 25-fold (FC25) and had a FPKM ≥1 in MES cells (Table S1 ). Analysis of Mel18, Ring1B, Cbx2, and Rybp ChIP-seq signal at these 98 genes clearly showed a positive signal over the IgG ChIP-seq ( Figure 5D ). While not all 98 genes contained a PRC1 subunit, 24 were bound by all four subunits ( Figure S5A ). Further, Rybp was present in more genes than Cbx2, reinforcing the concept that genes containing Rybp, rather than just any Cbx protein, are more expressed ( Figure S5A ). Genome-browser screenshots of the Ring1B, Mel18, Rybp, and Cbx2 ChIP-seq signal at some of the FC25 genes (Hand1, Lhx1, and Six2) and Gata4 are shown in Figure 5E . We then assessed whether these promoters, which were highly expressed yet contained PRC1 complexes, also contained H3K27me3. These four promoters (and in general, all the FC25 genes) were decorated not only with H3K4me3 and H3K36me3 but also with H3K27me3 ( Figure 5E ; Figure S5B ). Interestingly, the H3K4me3 profiles for the Hand1, Lhx1, and Six2 loci were not restricted to the TSS but rather resembled the broad H3K4me3 domains present in genes that define cell identity (Benayoun et al., 2014) . ChIP-qPCR assays confirmed that Ring1B, Rybp, and Mel18 co-bound to the promoter of these four genes ( Figures   S5C-S5D ). Similar to ESCs, Mel18 was required in MES cells for full Ring1B binding and H2AK119ub and H3K27me3 deposition, while Rybp binding remained unaltered ( Figure S5D, lower panel) . Not all FC25 genes contained PRC1 subunits in MES cells; for instance, Mel18 and Ring1B bind at high levels to T and Mesp1 in ESCs but were displaced from their promoters in MES cells ( Figures S5C and S5D ).
In ESCs, Cbx7 depletion reduces the chromatin binding for Mel18, but not Rybp (Morey et al., 2013) ; similarly, in Cbx2-depleted MES cells, Mel18 binding was partially reduced, while Rybp recruitment was either not affected or even slightly increased (Figure S5E ).
In addition to affecting the FC25 direct target genes, Mel18 depletion also downregulated FC25 genes that did not contain Polycomb proteins, implying a secondary effect probably mediated by the deregulation of FC25 genes bound by Mel18 ( Figure 5F , right panel); see also examples for Gata4, Lhx1, Hand1, Six2, and T expression after Mel18 depletion ( Figure 5G ; Table S1 ). The expression of genes containing Rybp but not Cbx2 was less affected by Mel18 depletion, suggesting that the Mel18 function was strongly associated to the cPRC1 complex ( Figure 5F , middle panel).
As controls, we first assured that our results were not affected by cell heterogeneity by FACS sorting to select the FLK1 + /Pdgfα + cell population (as differentiation of MES cells in vitro is never 100% efficient-we routinely achieved 70-80% of FLK1 + /Pdgfα + cells) ( Figure 5H ). We confirmed that the Gata4, Lhx1, Hand1, and Six2 promoters, but not the T or Mesp1 promoters, were bound by Mel18 and Cbx2 and were decorated with H3K27me3 in FLK1 + /Pdgfα + cells ( Figure 5I) , and that the expression of all six genes was very high in these cells as compared to ESCs ( Figure S5F ). Second, to rule out potential off-targets shRNA effects, we generated two Mel18 knock-out ESCs lines (named 12.1, and 12.2) by CRISPR/Cas9. Similar to the shMel18 ESCs, Phc1 protein levels were also strongly downregulated in both KO cell lines ( Figure   S5G ), and ChIP-qPCR assays confirmed that Mel18 was required for full Ring1B binding to chromatin ( Figure S5H ). MES-derived EBs from Mel18 KO cells were also affected ( Figure S5I ). Finally, ChIP experiments confirmed that Ring1B and Mel18 co-occupied the Gata4, Lhx1, Hand1, and Six2 promoters, and that Ring1B was strongly displaced in Mel18 KO MES cells ( Figure S5J ).
Mel18 Directly Controls Negative Regulators of the BMP Pathway in MES Cells
In addition to regulating genes implicated in early cardiac mesoderm precursor differentiation ( Figure 5D ), Mel18 also functions as a classical Polycomb protein ( Figure 4H-J) . As the BMP pathway needs to be tightly regulated during early mesoderm differentiation, Mel18 could also be involved in repressing negative regulators of the pathway to ensure its proper activation and function. Indeed, we found that Mel18, together with Ring1B, Rybp, and Cbx2, were bound to the promoter of four well-known negative regulators of the BMP pathway (Ramel and Hill, 2012) (Figure 6A ). ChIP-qPCR experiments confirmed that Ring1B and Mel18 co-occupy these four promoters, and that Ring1B recruitment was partially dependent on Mel18 ( Figure 6B) . Notably, Mel18 and Ring1B displacement in shMel18 cells resulted in upregulation of Nbl1 and Chrd ( Figure   6C ). Mechanistically, Chrd prevents BMP binding to its receptor (Larrain et al., 2000) , subsequently blocking the pathway, which in turn can be reestablished when high doses of BMP4 are delivered to the cells. Administrating 1 ng/ml of BMP4 to shMel18 cells induced re-expression of Flk1 and Mesp1 ( Figure 6D ).
Moreover, shMel18 MES EBs closely resembled the features of control MES EBs
( Figure 6E ).
Mel18 Depletion Blocks Cardiomyocyte and Cartilage Differentiation
We next determined whether shMel18 MES cells can terminally differentiate into beating cardiomyocytes. In accordance with our gene expression profiles, T protein levels were unaffected in Mel18-depleted cells during the course of ESC differentiation into MES cells, while Mesp1 protein levels were reduced but not completely abolished ( Figure 7A ). Mechanistically, both T and Mesp1 promoters showed reduced levels of Ring1B and Mel18 after induction of MES differentiation ( Figure S6A ). To generate cardiomyocyte precursors and beating cardiomyocytes, the EBs containing the MES cells needed to be disaggregated and plated in monolayer ( Figure 3A) . Disaggregated shMel18 MES cells attached to the plate as the wild-type and could be maintained in cardiac media; however, they did not grow in monolayers but rather formed cell clumps ( Figure 7B ).
Strikingly, very few shMel18 cells were capable of beating (Supplemental video 1 and 2). We observed that two contraction-associated proteins, cTnT (cardiac troponin T) and α-actinin, were strongly reduced in Mel18-depleted CMs ( Figure   7C ). To evaluate whether these cells remained undifferentiated or if Mel18 depletion resulted in cell fate changes, we performed RNA-seq experiments.
Around 1,500 genes were deregulated by at least 2-fold, and around 700 genes were deregulated by at least 3-fold, in Mel18-depleted CMs as compared to control CMs ( Figure 7D ). In contrast to shMel18 MES cells, more genes were upregulated in shMel18 CMs using both cut-offs ( Figure 5A ; Figure 7D ). Importantly, downregulated genes were mainly involved in heart development and function, and these were also Polycomb target genes in the heart ( Figure 7E ; Figure S6B ). Upregulated genes were strongly related to ESC genes and specifically, to different cardiomyopathies ( Figure 7F ; Figure S6C ). GO analysis of the deregulated genes using a five-fold cut-off revealed the same gene categories as observed when a two-fold cut-off was applied (data not shown).
To better understand the function of the deregulated genes in shMel18 CMs, we first analyzed the ESC, MES, and CM gene signatures. We defined the characteristic gene signature of each cell type (ESC, MES, and CM) as the set of genes expressed (FPKM ≥1) that are at least 5-fold upregulated as compared to the other cell types ( Figure 7G ). Analysis of genes deregulated by at least 2-fold in Mel18-depleted CMs compared to CM-specific genes revealed that 218 genes were downregulated, while 171 ESC-specific genes were upregulated ( Figure   7G ). In agreement with the previous analysis, downregulated genes were associated with ESCs ( Figure S6D) , and upregulated genes, to muscle system, heart development, and cardiac-associated diseases ( Figure S6E ).
RT-qPCR analysis of CM-specific proteins and transcription factors confirmed that cells lacking Mel18 did not properly differentiate into functional CMs ( Figure 7H) . As a control, we also performed the full cardiac differentiation assay using wild-type and Mel18 KO ESCs. Indeed, Mel18 KO cells also failed to express several cardiomyocyte genes ( Figure S6F ), and FACS analysis using a cTnT antibody confirmed that the population of beating CM was greatly reduced in these cells ( Figure S6G ).
In Mel18-depleted CMs, ESC markers were strongly upregulated, and cardiac markers, downregulated, while chondrocyte, neuroectoderm, endoderm, and hematopoietic genes were not expressed, confirming that shMel18 CM cells did not change their cell fate and are ultimately non-differentiated cells with a ESClike gene expression profile ( Figure S6H ; Table S1 ). Finally, we asked whether PRC1 subunits were differentially expressed in control CMs as compared to ESCs and MES cells. Cbx4, Phc3, and Pcgf5 were upregulated in CM cells, suggesting that alternative PRC1 complexes might exist in these cells (Figures S6I-S6J ).
Because Mel18 KO mice do not display evident defects in heart development, and as Pcgf5 is upregulated in CM cells, we hypothesized that Pcgf5 might be also involved in cardiomyocyte differentiation. We depleted Pcgf5 from ESCs ( Figure   S7A ) and then submitted these ESCs to EB differentiation (as for Figure 2C ).
shPcgf5 ESCs expressed normal levels of pluripotent markers and could be maintained in culture ( Figure S7B ). We observed that shPcgf5 EBs had a delay in their beating capacity, yet the effect was not as strong as that observed for shMel18 ESCs (Figure S7C-S7D ). This data suggest that Pcgf5 is also involved in cardiac differentiation in vitro. We then generated ESCs depleted for Mel18 and Pcgf5 to assess whether a Pcgf5 knock-down would have an additive effect on cells depleted for Mel18. Mel18/Pcgf5 KD ESCs can also be cultured, express normal pluripotency genes ( Figure S7E-G) , and levels of PRC1 members are similar to the shMel18-ESCs ( Figure S7H ). RT-qPCR analysis of control, shMel18, dKD control cells, and Mel18/Pcgf5 dKD 12-days-old EBs indicated that Pcgf5 cooperates with Mel18 during cardiac differentiation ( Figure S7I-J) .
Finally, we examined whether the Mel18 function during differentiation is restricted to cardiac cells or whether it is also necessary for differentiation of ESCs into other mesoderm-derived cells or cells derived from other cell lineages in vitro. We differentiated control and Mel18-depleted ESCs into cartilage cells (Craft et al., 2013) (Figure 7I ) and neuroprecursors (NPCs). Mel18-depleted cells were not capable to fully differentiate into cartilage cells ( Figures 7J-7K ), but efficiently differentiated into NPCs (Figures S7K-S7M ). RNA-seq experiments in control and shMel18 derived NPCs indicated that around 200 and 70 genes were up-or down-regulated by at least two-or three-fold, respectively, in Mel18-depleted cells. Analyzing the ESC and NPC gene signatures, we found that only 57 genes were downregulated, while 70 ESC-specific genes were upregulated ( Figure S70 ). GO analysis of these sets of genes did not show significant association to any biological process ( Figure S70 ). We therefore conclude that Mel18 specifically controls ESC differentiation towards mesoderm-derived cells but not towards other cell linages, such as neuroectoderm precursors.
Discussion
Here we propose Mel18 as a new epigenetic factor that specifically controls mesoderm differentiation by at least two opposite mechanisms. While Mel18 functions as a classical Polycomb gene in pluripotent cells, it is associated with a novel PRC1 complex that functions both as a repressor and an activator during early cardiac mesoderm cell differentiation ( Figure 7L ). We propose that Mel18 directly controls the activity of genes encoding transcription factors essential for early cardiac mesoderm cell specification, yet also directly controls the expression of the negative regulators of the BMP pathway and genes involved in late cardiac differentiation, pluripotency, and ectoderm and endoderm cell fate, to ensure their transcriptional repression in the early steps of cardiac differentiation.
Mutant Mel18 mice have an apparently normal heart (yet die shortly after birth, so that it is not clear how long this heart is functional). How can we explain this apparent inconsistency to our observation that Mel18 is an essential epigenetic factor implicated in cardiomyocyte differentiation in vitro? Inherent differences between in vitro and in vivo environments, such as local fluxes in vivo that could compensate differentiation challenges, could be partially responsible. For instance, we observed in vitro that increasing BMP4 rescued the differentiation defects of the Mel18 mutant cells, and local variations in BMP signaling occur in vivo, such as during gastrulation. Additionally, another Pcgf protein could compensate for the lack of Mel18 during heart development in vivo. One candidate could be Pcgf5, which we found to be strongly upregulated during late cardiomyocyte differentiation in vitro, and the depletion of which delayed cardiomyocyte differentiation. Further studies using mice with a conditional Mel18 mutant in the heart or with a double Mel18/Pcgf5 mutant will shed light about the in vivo contributions of Mel18 and other Pcgf proteins during heart development and homeostasis of the tissue. Finally, deregulated genes in Mel18-depleted CMs are related to cardiomyopathies. None of the genes previously reported to be mutated in cardiomyopathies were deregulated in Mel18-depleted CMs, suggesting that either Mel18 is a new gene associated to heart abnormalities, or that Mel18 controls molecular pathways deregulated in heart diseases. Further analyses both at the genetic and molecular levels are required to determine the possible role of PRC1 proteins in heart diseases.
Our functional and genome-wide studies suggest that Mel18 directly controls several pathways important for cardiomyocyte differentiation in vitro.
Mel18 positively regulates expression of essential transcription factors involved in early cardiac differentiation, suggesting a novel function of a Polycomb protein as a co-activator. One possibility could be that that expression of highly active genes containing cPRC1, ncPRC1, and PRC2 complexes is regulated by ncRNAs (such as enhancer RNAs) that cooperate with positive transcription regulators. Another characteristic of the MES-specific highly active genes containing Polycomb complexes was the presence of a specific breadth of the H3K4me3 domain and a particular deposition pattern of H3K36me3.
Interestingly, the breadth of broad H3K4me3 domains has been recently linked to transcriptional consistency at genes essential for cell identity (Benayoun et al., 2014) . Detailed analyses of these multivalent regions warrant further investigation.
It has been recently proposed that a PRC1 variant containing AUST2 and a phosphorylated form of Ring1B, but no Cbx proteins, binds to active genes in neurons (Gao et al., 2014) . Therefore, another possibility could be that the PRC1 complexes that regulate gene activity in MES cells also contain a posttranscriptionally modified Ring1B (or other subunit). Due to the lack of specific antibodies against the CK2-mediated Ring1B phosphorylated form, we could not assess whether this is the case in our cellular system. 
Experimental Procedures
Generation of Stable ESC Knock-Down Cultures
ESCs expressing stable pLKO-shRNA (Sigma) vectors against Mel18, Phc1, and Pcgf5 mRNAs were generated as previously described (Morey et al., 2013) . To generate Mel18/Pcgf5 double knock-down cells (dKD ESCs), shMel18 ESCs were transduced with lentiviruses expressing a shPcgf5-hygromycin vector. We also transduced the shCTR-ESCs with a pLKO-Hygromycin-control vector to generate ESCs resistant to puromycin and hygromycin (dKD control ESCs).
ChIP and Re-ChIP Assays
ChIP and re-ChIP experiments in ESCs were performed as previously described (Morey et al., 2013) . ChIP assays in MES cells were performed with the following modifications: MES cells were centrifuged 3 minutes at 800 rpm to discard cells that did not form embryoid bodies (EBs). EBs were trypsinized with TrypLE™ Express and then crosslinked, lysated, and sonicated as described for ESC ChIPs.
Antibodies and primers used for ChIP-qPCR are given in Table S1 .
Differentiation Assays
ESCs were differentiated into EBs and NPCs as previously described (Aloia et al., 2014; Morey et al., 2012) . Cardiomyocytes and cartilage differentiation assays were performed as previously described (Craft et al., 2013; Kattman et al., 2011) with the following modifications. In our hands, generation of highly-enriched population of MES cells was strongly influenced both by the dose and the batch of BMP4. Typically, we obtained the best differentiation results with 0.1-0.3 ng/ml of BMP4. We also noticed that the amount of MES cells seeded to obtain cardiac precursor cells was crucial to obtain a high percentage of beating cardiomyocytes, with the best results obtained when 125,000-150,000 MES cells were seeded in a 96-well plate. For cartilage differentiation, we also titrated the amount of BMP4 and number of cells; we obtained the best differentiation using 5 ng/ml of BMP4 and seeding 3000 cells in a 96-well plate.
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